Paskalis Charalampos

Paskalis Charalampos Intensive Care

Director, Adult Intensive Care Unit (ICU)

Education & Academic Qualifications

• Medical Degree from Aristotelian Univ. of Thessaloniki 1984 grade “Excellent” 9,2)
• Postdoctoral Fellow, NIH Bethesda MD and Frederick MD, USA 1984-1986
• Internal Medicine Specialty training 1986-1989, Providence Hospital, Washington, D.C
• Critical Care Fellowship, Mass. General Hosp, Boston MA, USA, 1989-1990
• Critical Care and Pulmonary Medicine Fellowship, Brigham and Women’s and Beth Israel Hosp, Boston MA, USA, 1990-1991
• American Boards in Internal Medicine 1989
• American Boards in Critical Care Medicine 1991
• Greek Boards in Internal Medicine 1992
• Greek Boards in Critical Care 1996

Board Member and Editorial Boards

• Member Greek Society of Critical Care Medicine
• Member Society of Critical Care Medicine
• Member European Society of Intensive Care Medicine

Professional Experience

• ICU Director “Aghios Loukas Hospital”, Thessaloniki  1991-1994
• ICU Director, Hygeia Hospital 1994-to date

Teaching Experience

• Regular teaching of postgraduate doctors, 2 sessions per year, 3 months each, for more than 10 years
• Regular teaching of nursing personnel, in training courses, at least 4 times per year

Clinical and Research Interest

Clinical Interest:
Critical Care Cardiology
ICU infections

Research Interest:  
Pharmacokinetics of advanced antibiotics in critically ill patients


• BK Felber, H Paskalis, C Kleinman-Ewing, F Wong-Staal and GN Pavlakis. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science, 1985; 229(4714): 675-679.
• H Paskalis, B K Felber and G N Pavlakis. Cis-acting sequences responsible for the transcriptional activation of HTLV-I constitute a conditional enhancer. PNAS, 1986; 83(17): 6558-6562.
• CM Wright, BK Felber, H Paskalis and GN Pavlakis. Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science, 1986; 234(4779): 988-92.
• Galani L, Souli M, Karaiskos I, Katsouda E, Patrozou H, Baziaka F, Paskalis C, Giamarellou H. Nosocomial dissemination of Providencia stuartii isolates producing extended-spectrum b-lactamases VEB-1 and SHV-5, metallo-b-lactamase VIM-1, and RNA methylase  RmtB.  J Global Antimicrob Res 2013; 1:115-116
• Chapter “Envenomation by insects and animals” in: Intensive Care, Ch. Roussos,  editor: Paschalidis Athens, Dec. 2009

ΜΗΤΕΡΑ: Αγγελία

Ο Όμιλος ΥΓΕΙΑ κατέχοντας ηγετική θέση στον τομέα των ιδιωτικών νοσοκομειακών μονάδων προκειμένου να καλύψει τις ανάγκες της συνεχούς ανάπτυξης του με στόχο την παροχή ιατρικών και νοσηλευτικών υπηρεσιών ποιοτικού επιπέδου, επιθυμεί να προσλάβει: ΙΑΤΡΟΥΣ ΒΙΟΠΑΘΟΛΟΓΟΥΣ για απασχόληση στα Κεντρικά Εργαστήρια.
Μάθετε περισσότερα..